CAMERON BROCCO: Open Payments
NPI 1851049324 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 39 payments from 15 companies in 2025. Trend: 2023 $466 · 2024 $809 · 2025 $674
Food & beverage: $614Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $139 |
| Novo Nordisk Inc | 6 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Astellas Pharma US Inc | 2 | $83 |
| Xeris Pharmaceuticals, Inc. | 2 | $74 |
| Lilly USA, LLC | 3 | $48 |
| PFIZER INC. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Cranial Technologies, Inc | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
Products named: OTEZLA, GVOKE HYPOPEN, AIRSUPRA, Ozempic, Wegovy, JARDIANCE, BREZTRI, Veozah.
Industry payments across TN — which companies pay providers there.
